网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
miR-338-3p调控头颈部鳞状细胞癌自噬、增殖、凋亡的作用及其机制
作者:谢立伟  杨浩  杨洁 
单位:资阳市第一人民医院 皮肤科, 四川 资阳 641300
关键词:miR-338-3p/RAB23 头颈部鳞状细胞癌 增殖 凋亡 自噬 
分类号:R739.91
出版年·卷·期(页码):2022·50·第三期(273-279)
摘要:

目的:研究miR-338-3p调控头颈部鳞状细胞癌(HNSCC)自噬、增殖、凋亡的作用及其机制。方法:以实时荧光定量聚合酶链反应(qRT-PCR)检测miR-338-3p在HNSCC组织及癌旁组织中的表达。体外培养人头颈鳞癌细胞株PCI-37A,随机分为对照组、miR-338-3p mimics阴性对照组、miR-338-3p mimics组,分组转染后,以细胞计数试剂盒-8(CCK-8)实验和流式细胞术分别检测各组细胞增殖、凋亡情况;以吖啶橙染色检测各组细胞自噬水平;以qRT-PCR检测各组细胞miR-338-3p、RAS癌基因家族成员RAB23 mRNA水平;以免疫印迹法检测各组细胞RAB23、自噬和凋亡相关蛋白表达水平。结果:相比癌旁组织,miR-338-3p在HNSCC组织中表达明显下降(P<0.05)。相比对照组,miR-338-3p mimics组细胞相对生存率、自噬溶酶体相对含量、RAB23 mRNA和蛋白表达水平、B淋巴细胞瘤-2(Bcl-2)及Beclin-1、微管相关蛋白1轻链3B(LC3B)蛋白表达水平明显降低(P<0.05),凋亡率、miR-338-3p水平、BCL2相关X蛋白(Bax)蛋白表达水平明显升高(P<0.05);miR-338-3p mimics阴性对照组细胞各指标无明显变化(P>0.05)。结论:miR-338-3p在HNSCC组织中低表达;上调其表达,可抑制RAB23表达,降低癌细胞自噬水平,抑制癌细胞增殖并促使其凋亡。

Objective: To study the role and mechanism of miR-338-3p in regulating autophagy, proliferation and apoptosis of head and neck squamous cell carcinoma(HNSCC). Methods: The expression of miR-338-3p in HNSCC and adjacent tissues was detected by real-time fluorescence quantitative polymerase chain reaction(qRT-PCR). Human head and neck squamous cell PCI-37A were cultured in vitro and randomly divided into control group, miR-338-3p mimics negative control group and miR-338-3p mimics group. After transfection, cell proliferation and apoptosis were detected by cell counting kit-8(CCK-8) assay and flow cytometry; the level of autophagy was detected by acridine orange staining; the levels of miR-338-3p and member RAS oncogene family RAB23 mRNA were detected by qRT-PCR; the expression levels of RAB23, autophagy and apoptosis related proteins were detected by Western blot. Results: Compared with that in the adjacent tissues, the expression of miR-338-3p in HNSCC was significantly lower(P<0.05). Compared with those in the control group, the relative survival rate, the relative content of autophagy lysosome, the expression levels of RAB23 mRNA and protein, the expression levels of B-cell lymphoma-2(Bcl-2), Beclin-1 and microtubule-associated protein 1 light chain 3B(LC3B) were significantly lower in miR-338-3p mimics group(P<0.05), the apoptosis rate, level of miR-338-3p and expression level of BCL2-associated X protein(Bax) protein were significantly higher(P<0.05); in miR-338-3p mimics negative control group, there were no significant changes in cell indexes(P>0.05). Conclusion: MiR-338-3p is down-regulated in HNSCC. Up-regulation of miR-338-3p can inhibit RAB23 expression, reduce autophagy level, inhibit proliferation and promote apoptosis of HNSCC.

参考文献:

[1] LEE Y S,JOHNSON D E,GRANDIS J R.An update:emerging drugs to treat squamous cell carcinomas of the head and neck[J].Expert Opin Emerg Dr,2018,23(4):283-299.
[2] WANG X,BEITLER J J,HUANG W,et al.Honokiol radiosensitizes squamous cell carcinoma of the head and neck by downregulation of survivin[J].Clin Cancer Res,2018,24(4):858-869.
[3] DU X,LIU B,LUAN X,et al.miR30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy[J].Exp Ther Med,2018,15(1):599-605.
[4] LIU W,WANG X,WANG Y,et al.SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT[J].J Exp Clin Cancer Res,2018,37(1):73-84.
[5] 陈兰,刘晓,陈小菊,等.自噬在肺癌靶向治疗耐药中作用的研究进展[J].现代医学,2021,49(4):470-474.
[6] 王文静,王晓霏,刘利英,等.miR-338-3p在恶性肿瘤中的表达异常及其表观遗传组蛋白的修饰位点[J].西安交通大学学报(医学版),2019,40(5):706-710.
[7] CAO Y,SHI X,LIU Y,et al.MicroRNA-338-3p inhibits proliferation and promotes apoptosis of multiple myeloma cells through targeting cyclin-dependent kinase 4[J].Oncol Res,2018,27(1):117-124.
[8] JIAO Z H,WANG J D,WANG X J.MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23[J].Eur Rev Med Pharmacol Sci,2018,22(9):2598-2605.
[9] WANG Y,QIN H.miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells[J].Am J Cancer Res,2018,8(12):2564-2574.
[10] ZHENG L Q,CHI S M,LI C X.Rab23's genetic structure,function and related diseases:a review[J].Biosci Rep,2017,37(2):BSR20160410.
[11] CHANDRASHEKAR D S,BASHEL B,BALASUBRAMANYA S A H,et al.UALCAN:a portal for facilitating tumor subgroup gene expression and survival analyses[J].Neoplasia,2017,19(8):649-658.
[12] ZOU T,DUAN J,LIANG J,et al.miR-338-3p suppresses colorectal cancer proliferation and progression by inhibiting MACC1[J].Int J Clin Exp Pathol,2018,11(4):2256-2267.
[13] SHEN W,SAKAMOTO N,YANG L.Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck:a competing risk analysis[J].J Cancer,2018,9(21):4009-4017.
[14] PLATEK A,MIX M D,CHAUDHRI V,et al.In the era of PET scans,is unilateral radiation therapy enough to treat squamous cell carcinomas of the head and neck from an unknown primary?[J].Int J Radiat Oncol Biol Phys,2018,100(5):1329-1330.
[15] 徐召南,毕也,王溪,等.自噬对口腔鳞状细胞癌CAL-27和KB细胞放疗敏感性的影响及其机制[J].吉林大学学报(医学版),2016,42(4):716-720.
[16] 陈昌瀚,朱刚才,皮雷鸣,等.细胞自噬在头颈部鳞状细胞癌侵袭转移中的作用[J].临床耳鼻咽喉头颈外科杂志,2017,31(10):789-793,796.
[17] GUO B,ZHANG J,LI Q,et al.Hypermethylation of miR-338-3p and impact of its suppression on cell metastasis through N-cadherin accumulation at the cell-cell junction and degradation of MMP in gastric cancer[J].Cell Physiol Biochem,2018,50(2):411-425.
[18] JIA F,ZHANG Z,ZHANG X.MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway[J].J Cell Biochem,2018,120(4):6420-6430.
[19] ZHANG W J,YU F,WANG Y,et al.Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway[J].Oncol Lett,2018,15(4):5155-5160.
[20] ZHAO T,HAN D,MENG H.Rab23 contributes to the progression of colorectal cancer via protein kinase B and extracellular signalregulated kinase signaling pathways[J].Oncol lett,2019,18(2):1793-1799.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 743563 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541